Your browser doesn't support javascript.
loading
Show: 20 | 50 | 100
Results 1 - 7 de 7
Filter
1.
Apoptosis ; 18(6): 739-50, 2013 Jun.
Article in English | MEDLINE | ID: mdl-23456623

ABSTRACT

TNF-related apoptosis-inducing ligand (TRAIL) is a pro-apoptotic ligand from the TNF-alpha family that is under consideration, along with agonistic anti-TRAIL receptor antibodies, as a potential anti-tumor agent. However, most primary human tumors are resistant to monotherapy with TRAIL apoptogens, and thus the potential applicability of TRAIL in anti-tumor therapy ultimately depends on its rational combination with drugs targeting these resistances. In our high-throughput screening for novel agents/drugs that could sensitize TRAIL-resistant colorectal cancer cells to TRAIL-induced apoptosis, we found homoharringtonine (HHT), a cephalotaxus alkaloid and tested anti-leukemia drug, to be a very effective, low nanomolar enhancer of TRAIL-mediated apoptosis/growth suppression of these resistant cells. Co-treatment of TRAIL-resistant RKO or HT-29 cells with HHT and TRAIL led to the effective induction of apoptosis and the complete elimination of the treated cells. HHT suppressed the expression of the anti-apoptotic proteins Mcl-1 and cFLIP and enhanced the TRAIL-triggered activation of JNK and p38 kinases. The shRNA-mediated down-regulation of cFLIP or Mcl-1 in HT-29 or RKO cells variably enhanced their TRAIL-induced apoptosis but it did not markedly sensitize them to TRAIL-mediated growth suppression. However, with the notable exception of RKO/sh cFLIP cells, the downregulation of cFLIP or Mcl-1 significantly lowered the effective concentration of HHT in HHT + TRAIL co-treatment. Combined HHT + TRAIL therapy also led to the strong suppression of HT-29 tumors implanted into immunodeficient mice. Thus, HHT represents a very efficient enhancer of TRAIL-induced apoptosis with potential application in TRAIL-based, anti-cancer combination therapy.


Subject(s)
Apoptosis/drug effects , Drug Resistance, Neoplasm/drug effects , Harringtonines/pharmacology , TNF-Related Apoptosis-Inducing Ligand/pharmacology , Animals , Apoptosis Regulatory Proteins/metabolism , HT29 Cells , Homoharringtonine , Humans , Mice , Mice, Inbred NOD , Mice, SCID , Neoplasm Transplantation , Transplantation, Heterologous
2.
Phys Chem Chem Phys ; 14(42): 14516-22, 2012 Nov 14.
Article in English | MEDLINE | ID: mdl-22870507

ABSTRACT

Although there were experimental indications that phospholipid bilayers hydrated with D(2)O express different biophysical properties compared with hydration by ordinary H(2)O, a molecular concept for this behavior difference was only recently proposed by a molecular dynamics simulations study [T. Róg et al., J. Phys. Chem. B, 2009, 113, 2378-2387]. Here we attempt to verify those theoretical predictions by fluorescence measurements on 1,2-dimyristoyl-sn-glycero-3-phosphocholine (DMPC) and 1-palmitoyl-2-oleoyl-sn-glycero-3-phosphocholine (POPC) membranes. Specifically, we determine the water isotope effect on headgroup hydration and mobility, lateral lipid diffusion and lipid backbone packing. Time-dependent fluorescence shift experiments show significantly slower dynamics and lower hydration of the headgroup region for a bilayer hydrated with D(2)O, an observation in good agreement with the calculated predicted differences in duration of lipid-lipid and lipid-water bridges and extent of water penetration into the bilayer, respectively. The water isotope effect on the lipid order parameter of the bilayer core (measured by fluorescence anisotropy) and lateral diffusion of lipid molecules (determined by two-focus fluorescence correlation spectroscopy) is close to the experimental errors of the experiments, however also refers to slightly more rigid organization of phospholipid bilayers in heavy water. This study confirms the view that the water isotope effect can be particularly found in time-resolved physicochemical properties of the membrane. Together with the simulations our experiments provide a comprehensive, molecular view on the effect of D(2)O on phospholipid bilayers.


Subject(s)
Deuterium Oxide/chemistry , Lipid Bilayers/chemistry , Molecular Dynamics Simulation , Phospholipids/chemistry , Fluorescence , Molecular Conformation , Time Factors
3.
Sci Rep ; 11(1): 8171, 2021 04 14.
Article in English | MEDLINE | ID: mdl-33854130

ABSTRACT

Later stages of secondary lymphedema are associated with the massive deposition of adipose tissue (AT). The factors driving lymphedema-associated AT (LAT) expansion in humans remain rather elusive. We hypothesized that LAT expansion could be based on alterations of metabolic, adipogenic, immune and/or angiogenic qualities of AT. AT samples were acquired from upper limbs of 11 women with unilateral breast cancer-related lymphedema and 11 healthy women without lymphedema. Additional control group of 11 female breast cancer survivors without lymphedema was used to assess systemic effects of lymphedema. AT was analysed for adipocyte size, lipolysis, angiogenesis, secretion of cytokines, immune and stem cell content and mRNA gene expression. Further, adipose precursors were isolated and tested for their proliferative and adipogenic capacity. The effect of undrained LAT- derived fluid on adipogenesis was also examined. Lymphedema did not have apparent systemic effect on metabolism and cytokine levels, but it was linked with higher lymphocyte numbers and altered levels of several miRNAs in blood. LAT showed higher basal lipolysis, (lymph)angiogenic capacity and secretion of inflammatory cytokines when compared to healthy AT. LAT contained more activated CD4+ T lymphocytes than healthy AT. mRNA levels of (lymph)angiogenic markers were deregulated in LAT and correlated with markers of lipolysis. In vitro, adipose cells derived from LAT did not differ in their proliferative, adipogenic, lipogenic and lipolytic potential from cells derived from healthy AT. Nevertheless, exposition of preadipocytes to LAT-derived fluid improved their adipogenic conversion when compared with the effect of serum. This study presents results of first complex analysis of LAT from upper limb of breast cancer survivors. Identified LAT alterations indicate a possible link between (lymph)angiogenesis and lipolysis. In addition, our in vitro results imply that AT expansion in lymphedema could be driven partially by exposition of adipose precursors to undrained LAT-derived fluid.


Subject(s)
Adipose Tissue/metabolism , Breast Cancer Lymphedema/genetics , Cytokines/genetics , Gene Expression Profiling/methods , Lymphedema/genetics , Adult , Aged , Breast Cancer Lymphedema/metabolism , Cancer Survivors , Case-Control Studies , Female , Gene Expression Regulation , Humans , Lipolysis , Lymphedema/metabolism , Middle Aged
4.
Langmuir ; 26(9): 6140-4, 2010 May 04.
Article in English | MEDLINE | ID: mdl-20387820

ABSTRACT

Physical properties of oxidized phospholipid (OxPL) membranes consisting of binary mixtures of 1-palmitoyl-2-oleoyl-sn-glycero-3-phosphocholine (POPC) and 10 mol % of one of two OxPLs, 1-palmitoyl-2-glutaryl-sn-glycero-3-phosphocholine (PGPC) or 1-palmitoyl-2-(5'-oxo-valeroyl)-sn-glycero-3-phosphocholine (POVPC), were investigated experimentally and computationally. Fluorescence solvent relaxation (SR) and fluorescence correlation spectroscopy z-scan (FCS z-scan) show increased headgroup hydration and mobility, and faster lateral diffusion in POPC membrane upon addition of OxPLs. The magnitudes of both effects are distinct for each of the two OxPLs. Molecular dynamics simulations corroborate the experimental findings, providing at the same time a detailed molecular interpretation in terms of changes in bilayer structure and phospholipid orientation.


Subject(s)
Lipid Bilayers/chemistry , Molecular Dynamics Simulation , Phospholipids/chemistry , Physical Phenomena , Cell Membrane/chemistry , Diffusion , Oxidation-Reduction , Phosphatidylcholines/chemistry , Phospholipid Ethers/chemistry , Solvents/chemistry , Spectrometry, Fluorescence
5.
J Phys Chem B ; 112(51): 16823-9, 2008 Dec 25.
Article in English | MEDLINE | ID: mdl-19367896

ABSTRACT

Within the past decade single molecule techniques contributed significantly to the understanding of the mechanism of DNA condensation induced by various kinds of condensers. While observation of single DNA molecules bigger than 100 kbp (kilobasepairs) can be achieved by fluorescence microscopy, smaller DNA molecules can be visualized directly only via methods allowing higher resolution like atomic force microscopy (AFM), with the drawback that the observed particles interfere with the surface. Here, we introduce a robust utilization of a novel technique based on the detection of single molecules, fluorescence lifetime correlation spectroscopy (FLCS). The method simultaneously determinates diffusion coefficients and fluorescence lifetime. We demonstrate that FLCS can distinguish between different compaction mechanisms of DNA molecules being even smaller than the resolution of a fluorescence microscope. The success of this unique technique is based on the fact that FLCS allows for characterizing the diffusion properties of the condensed forms exclusively in presence of uncondensed DNA molecules. We focus on the condensation mechanism of circular 10 and linear 49 kbp DNA induced by spermine and cetyltrimethylammonium bromide (CTAB). We show that spermine induces an all-or-none transition, while the condensation with CTAB is gradual. The conclusions drawn are furthermore supported by two standard techniques, dynamic light scattering (DLS), and fluorescence correlation spectroscopy (FCS).


Subject(s)
Cations/chemistry , Spectrometry, Fluorescence/methods , Surface-Active Agents/chemistry , Scattering, Radiation
6.
Faraday Discuss ; 161: 499-513; discussion 563-89, 2013.
Article in English | MEDLINE | ID: mdl-23805755

ABSTRACT

Membranes undergo severe changes under oxidative stress conditions due to the creation of oxidized phospholipid (OxPL) species, which possess molecular properties quite different from their parental lipid components. These OxPLs play crucial roles in various pathological disorders and their occurrence is involved in the onset of intrinsic apoptosis, a fundamental pathway in programmed mammalian cell death. However, the molecular mechanisms by which these lipids can exert their apoptotic action via their host membranes (e.g., altering membrane protein function) are poorly understood. Therefore, we studied the impact of OxPLs on the organization and biophysical properties of 1,2-dimyristoyl-sn-glycero-3-phosphocholine (DMPC) based lipid membranes by differential scanning calorimetry (DSC) and solid state nuclear magnetic resonance (NMR) spectroscopy. Incorporation of defined OxPLs with either a carboxyl group (1-palmitoyl-2-azelaoyl-sn-glycero-3-phosphocholine (PazePC)) or aldehyde (1-palmitoyl-(9'oxononanoyl)-sn-glycero-3-phosphocholine (PoxnoPC)) at their truncated sn-2-chain ends enabled us to reveal OxPL species-dependent differences. The calorimetric studies revealed significant effects of OxPLs on the thermotropic phase behavior of DMPC bilayers, especially at elevated levels where PazePC induced more pronounced effects than PoxnoPC. Temperature-dependent changes in the solid state 31P NMR spectra, which provided information of the lipid headgroup region in these mixed membrane systems, reflected this complex phase behavior. In the temperature region between 293 K (onset of the Lalpha-phase) and 298 K, two overlapping NMR spectra were visible which reflect the co-existence of two liquid-crystalline lamellar phases with presumably one reflecting OxPL-poor domains and the other OxPL-rich domains. Deconvolution of the DSC profiles also revealed these two partially overlapping thermal events. In addition, a third thermal, non-NMR-visible, event occurred at low temperatures, which can most likely be associated to a solid-phase mixing/demixing process of the OxPL-containing membranes. The observed phase transitions were moved to higher temperatures in the presence of heavy water due its condensing effect, where additional wideline 2H-NMR studies revealed a complex hydration pattern in the presence of OxPLs.


Subject(s)
Membrane Lipids/chemistry , Phospholipids/chemistry , Calorimetry, Differential Scanning , Dimyristoylphosphatidylcholine/chemistry , Lipid Bilayers/chemistry , Magnetic Resonance Spectroscopy , Membrane Lipids/metabolism , Oxidation-Reduction , Phospholipids/metabolism , Phosphorylcholine/analogs & derivatives , Phosphorylcholine/chemistry , Temperature
7.
Leuk Lymphoma ; 54(2): 372-80, 2013 Feb.
Article in English | MEDLINE | ID: mdl-22830613

ABSTRACT

Tumor necrosis factor-related apoptosis-inducing ligand (TRAIL) is a death ligand with selective antitumor activity. However, many primary tumors are TRAIL resistant. Previous studies reported that roscovitine, a cyclin-dependent kinase inhibitor, sensitized various solid cancer cells to TRAIL. We show that roscovitine and TRAIL demonstrate synergistic cytotoxicity in hematologic malignant cell lines and primary cells. Pretreatment of TRAIL-resistant leukemia cells with roscovitine induced enhanced cleavage of death-inducing signaling complex-bound proximal caspases after exposure to TRAIL. We observed increased levels of both pro- and antiapoptotic BCL-2 proteins at the mitochondria following exposure to roscovitine. These results suggest that roscovitine induces priming of cancer cells for death by binding antiapoptotic BCL-2 proteins to proapoptotic BH3-only proteins at the mitochondria, thereby decreasing the threshold for diverse proapoptotic stimuli. We propose that the mitochondrial priming and enhanced processing of apical caspases represent major molecular mechanisms of roscovitine-induced sensitization to TRAIL in leukemia/lymphoma cells.


Subject(s)
Antineoplastic Agents/pharmacology , Apoptosis/drug effects , Leukemia/metabolism , Lymphoma/metabolism , Purines/pharmacology , TNF-Related Apoptosis-Inducing Ligand/pharmacology , Animals , Cell Line, Tumor , Cytotoxicity, Immunologic/drug effects , Death Domain Receptor Signaling Adaptor Proteins/metabolism , Fas Ligand Protein/pharmacology , Humans , Leukemia/genetics , Leukemia/pathology , Lymphoma/genetics , Lymphoma/pathology , Mice , Mitochondria/drug effects , Mitochondria/metabolism , Myeloid Cell Leukemia Sequence 1 Protein , Protein Biosynthesis/drug effects , Proto-Oncogene Proteins c-bcl-2/metabolism , Roscovitine , Transcription, Genetic/drug effects , Tumor Burden/drug effects , Tumor Necrosis Factor-alpha/pharmacology , Xenograft Model Antitumor Assays , bcl-X Protein/metabolism
SELECTION OF CITATIONS
SEARCH DETAIL